Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Autoantibodies are associated with disease progression in idiopathic pulmonary fibrosis.
Koether K, Besnard V, Sandig H, Carruthers A, Miranda E, Grootenboer-Mignot S, Taillé C, Chevret S, Valeyre D, Nunes H, Israel-Biet D, Lim WK, Cottin V, Corkill D, Dobson C, Groves M, Ferraro F, Guenzi E, Huang L, Sulikowski M, Mailleux A, Murray LA, Mustelin T, Strickland I, Sleeman MA, Crestani B. Koether K, et al. Among authors: grootenboer mignot s. Eur Respir J. 2023 May 18;61(5):2102381. doi: 10.1183/13993003.02381-2021. Print 2023 May. Eur Respir J. 2023. PMID: 37080573
Paraneoplastic pemphigus uncovers distinct clinical and biological phenotypes of western unicentric Castleman disease.
Dieudonné Y, Silvestrini MA, Dossier A, Meignin V, Jouenne F, Mahévas T, Bouaziz JD, Jackson MA, Mordant P, Poirot J, Onodi F, Calvani J, Hourseau M, Evrard D, Berisha M, Perrin F, Danel C, Borie R, Galicier L, Mourah S, Bengoufa D, Oksenhendler E, Grootenboer-Mignot S, Boutboul D. Dieudonné Y, et al. Among authors: grootenboer mignot s. Br J Haematol. 2023 Jul;202(2):267-278. doi: 10.1111/bjh.18847. Epub 2023 May 23. Br J Haematol. 2023. PMID: 37221131
Lichen planus pemphigoides with predominant mucous membrane involvement: a series of 12 patients and a literature review.
Combemale L, Bohelay G, Sitbon IY, Ahouach B, Alexandre M, Martin A, Pascal F, Soued I, Doan S, Morin F, Grootenboer-Mignot S, Caux F, Prost-Squarcioni C, Le Roux-Villet C. Combemale L, et al. Among authors: grootenboer mignot s. Front Immunol. 2024 Apr 15;15:1243566. doi: 10.3389/fimmu.2024.1243566. eCollection 2024. Front Immunol. 2024. PMID: 38686381 Free PMC article.
Omalizumab in the treatment of bullous pemphigoid resistant to first-line therapy: a French national multicentre retrospective study of 100 patients.
Chebani R, Lombart F, Chaby G, Dadban A, Debarbieux S, Viguier MA, Ingen-Housz-Oro S, Pham-Ledard A, Bedane CR, Picard-Dahan C, Berthin C, Dereure O, Konstantinou MP, Castel M, Jouen F, Joly P, Seta V, Duvert-Lehembre S, Le Roux C, Quereux G, Sassolas B, Brenaut E, Sin C, Richard MA, Bérard F, Giusti D, Belmondo T, Gille T, Caux F, Prost-Squarcioni C, Grootenboer-Mignot S, Alexandre M; French Study Group on Autoimmune Bullous Diseases. Chebani R, et al. Among authors: grootenboer mignot s. Br J Dermatol. 2024 Jan 23;190(2):258-265. doi: 10.1093/bjd/ljad369. Br J Dermatol. 2024. PMID: 37792727
Rituximab Therapy for Mucous Membrane Pemphigoid: A Retrospective Monocentric Study With Long-Term Follow-Up in 109 Patients.
Bohelay G, Alexandre M, Le Roux-Villet C, Sitbon I, Doan S, Soued I, Shourick J, Rousset L, Mellottee B, Heller M, Lièvre N, Zumelzu C, Morin F, Grootenboer-Mignot S, Gabison E, Caux F, Prost-Squarcioni C, Musette P. Bohelay G, et al. Among authors: grootenboer mignot s. Front Immunol. 2022 Jun 30;13:915205. doi: 10.3389/fimmu.2022.915205. eCollection 2022. Front Immunol. 2022. PMID: 35844526 Free PMC article.
IgA and IgG/IgA intercellular dermatosis: a clinicopathological case series of 15 patients.
Calmettes V, Badrignans M, Konstantinou MP, Tancrède-Bohin E, Vignon-Pennamen MD, Castel M, Pham-Ledard A, Le Roux-Villet C, Misery L, Schoenlaub P, Tronquoy AF, Cordel N, Ortonne N, Sohier P, Cellier L, Tournier E, De La Salle EM, Le Flahec G, Plantier F, Grootenboer-Mignot S, Jouen F, Hillion B, Aractingi S, Duvert-Lehembre S, Dupin N, Ingen-Housz-Oro S; French Bullous Diseases Study Group. Calmettes V, et al. Among authors: grootenboer mignot s. J Eur Acad Dermatol Venereol. 2022 Nov;36(11):e896-e898. doi: 10.1111/jdv.18325. Epub 2022 Jun 21. J Eur Acad Dermatol Venereol. 2022. PMID: 35694900 No abstract available.
Rapid Disease Control in First-Line Therapy-Resistant Mucous Membrane Pemphigoid and Bullous Pemphigoid with Omalizumab as Add-On Therapy: A Case Series Of 13 Patients.
Alexandre M, Bohelay G, Gille T, Le Roux-Villet C, Soued I, Morin F, Caux F, Grootenboer-Mignot S, Prost-Squarcioni C. Alexandre M, et al. Among authors: grootenboer mignot s. Front Immunol. 2022 Apr 20;13:874108. doi: 10.3389/fimmu.2022.874108. eCollection 2022. Front Immunol. 2022. PMID: 35514989 Free PMC article.
Non-coeliac gluten sensitivity: an underdiagnosed condition in dermatology?
Common M, El Khalifa J, Beytout Q, Grootenboer-Mignot S, Deschamps L, Descamps V. Common M, et al. Among authors: grootenboer mignot s. J Eur Acad Dermatol Venereol. 2022 Feb;36(2):e102-e104. doi: 10.1111/jdv.17642. Epub 2021 Sep 15. J Eur Acad Dermatol Venereol. 2022. PMID: 34487592 No abstract available.
Paraneoplastic Pemphigus Revealed by Anti-programmed Death-1 Pembrolizumab Therapy for Cutaneous Squamous Cell Carcinoma Complicating Hidradenitis Suppurativa.
Yatim A, Bohelay G, Grootenboer-Mignot S, Prost-Squarcioni C, Alexandre M, Le Roux-Villet C, Martin A, Maubec E, Caux F. Yatim A, et al. Among authors: grootenboer mignot s. Front Med (Lausanne). 2019 Nov 5;6:249. doi: 10.3389/fmed.2019.00249. eCollection 2019. Front Med (Lausanne). 2019. PMID: 31750309 Free PMC article.
36 results